Glenn Muir Net Worth & Insider Trades

Glenn Muir G1 Therapeutics, Inc

As of June 16, 2023

What is Glenn Muir's Net Worth?

The current estimated net worth of G1 Therapeutics, Inc's Glenn Muir is estimated to be about $80.2M . Glenn Muir owns about 170,969 units of G1 Therapeutics, Inc common stock. In the last 6 years at G1 Therapeutics, Inc, Glenn Muir has sold an estimated value of $0 worth.

What is Glenn Muir's Past Insider Trading?

Glenn Muir's largest purchase order was 50,000 units , worth over $675K on November 19, 2020. In total, Glenn Muir has made about 9 transactions over 6 years of their time at G1 Therapeutics, Inc. Glenn Muir usually trades in June, with the busiest year in 2020 and 2017.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Price per Share
Filing Date
No matching records found


Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Glenn Muir's' Mailing Address?

  • Mailing address is C/o Hologic, Inc. Bedford MA 01730 MA

G1 Therapeutics, Inc Executive Compensation

Option Awards
Other Earnings Plans or Compensations
Other Compensation
John E. Bailey, Jr. 2020 - $542,109 - $215,948 $758,057
Mark A. Velleca, M.D., Ph.D. 2020 $608,308 $3,069,704 $305,000 $8,550 $3,991,562
Mark A. Velleca, M.D., Ph.D. 2019 $589,700 $3,105,237 $280,108 $8,400 $3,983,445
Mark A. Velleca, M.D., Ph.D. 2018 $515,000 $1,044,529 $321,875 $33,250 $1,914,654
Jennifer K. Moses 2020 $398,583 $1,116,239 $141,050 $8,550 $1,664,422
Jennifer K. Moses 2019 $315,598 $972,601 $117,600 $8,400 $1,414,199
Mark Avagliano 2020 $431,417 $837,165 $151,200 $18,445 $1,438,227
Mark Avagliano 2019 $181,913 $5,100,560 $142,800 $53,117 $5,478,390
Rajesh K. Malik, M.D. 2020 $424,000 $836,733 $148,750 $8,550 $1,418,033
Rajesh K. Malik, M.D. 2019 $413,000 $828,195 $138,768 $8,400 $1,388,363
Rajesh K. Malik, M.D. 2018 $400,000 $696,968 $169,400 $8,250 $1,274,618
Soma Gupta 2020 $320,360 $2,212,758 $114,662 $100,000 $2,747,780
No matching records found


What are G1 Therapeutics, Inc's Past Insider Trades?

G1 Therapeutics, Inc's most recent insider trade came on August 10, 2023 by Mark Velleca who sold 60,000 units worth $119.97K . In the last 6 years, insiders at G1 Therapeutics, Inc have sold an estimated value of $69.83M and bought an estimated value of $25.78M worth of shares. Insider trading is most common in January and June, with the busiest year in 2018. The most active traders at the company are Rajesh Malik, Chief Medical Officer,  Mark Velleca,  and Jennifer Moses, CFO .

G1 Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Price per Share
Filing Date
No matching records found